Literature DB >> 11799030

Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis.

Andreas Schapowal1.   

Abstract

OBJECTIVES: To compare the efficacy and tolerability of butterbur (Petasites hybridus) with cetirizine in patients with seasonal allergic rhinitis (hay fever).
DESIGN: Randomised, double blind, parallel group comparison.
SETTING: Four outpatient general medicine and allergy clinics in Switzerland and Germany. PARTICIPANTS: 131 patients were screened for seasonal allergic rhinitis and 125 patients were randomised (butterbur 61; cetirizine 64).
INTERVENTIONS: Butterbur (carbon dioxide extract tablets, ZE 339) one tablet, four times daily, or cetirizine, one tablet in the evening, both given for two consecutive weeks. MAIN OUTCOME MEASURES: Scores on SF-36 questionnaire and clinical global impression scale.
RESULTS: Improvement in SF-36 score was similar in the two treatment groups for all items tested hierarchically. Butterbur and cetirizine were also similarly effective with regard to global improvement scores on the clinical global impression scale (median score 3 in both groups). Both treatments were well tolerated. In the cetirizine group, two thirds (8/12) of reported adverse events were associated with sedative effects (drowsiness and fatigue) despite the drug being considered a non-sedating antihistamine.
CONCLUSIONS: The effects of butterbur are similar to those of cetirizine in patients with seasonal allergic rhinitis when evaluated blindly by patients and doctors. Butterbur should be considered for treating seasonal allergic rhinitis when the sedative effects of antihistamines need to be avoided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799030      PMCID: PMC64514          DOI: 10.1136/bmj.324.7330.144

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  11 in total

1.  LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.

Authors:  D Wheatley
Journal:  Pharmacopsychiatry       Date:  1997-09       Impact factor: 5.788

2.  Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire.

Authors:  J Bousquet; J Duchateau; J C Pignat; C Fayol; P Marquis; S Mariz; J E Ware; B Valentin; B Burtin
Journal:  J Allergy Clin Immunol       Date:  1996-08       Impact factor: 10.793

3.  Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study.

Authors:  R Schellenberg
Journal:  BMJ       Date:  2001-01-20

4.  Descriptive data analysis: a concept between confirmatory and exploratory data analysis.

Authors:  K Abt
Journal:  Methods Inf Med       Date:  1987-04       Impact factor: 2.176

5.  Gastro-protective effects by extracts of Petasites hybridus: the role of inhibition of peptido-leukotriene synthesis.

Authors:  K Brune; D Bickel; B A Peskar
Journal:  Planta Med       Date:  1993-12       Impact factor: 3.352

6.  Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.

Authors:  H Woelk
Journal:  BMJ       Date:  2000-09-02

7.  Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.

Authors:  H R Knapp
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

8.  Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus.

Authors:  O A Thomet; U N Wiesmann; A Schapowal; C Bizer; H U Simon
Journal:  Biochem Pharmacol       Date:  2001-04-15       Impact factor: 5.858

9.  Identification and characterization of inhibitors of peptido-leukotriene-synthesis from Petasites hybridus.

Authors:  D Bickel; T Röder; H J Bestmann; K Brune
Journal:  Planta Med       Date:  1994-08       Impact factor: 3.352

Review 10.  Allergic rhinitis: mechanisms and management.

Authors:  B A Berman
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

View more
  15 in total

1.  Treating seasonal allergic rhinitis. Well designed experiments should have been used.

Authors:  Sam Shuster
Journal:  BMJ       Date:  2002-05-25

2.  Hayfever--practical management issues.

Authors:  Andrew Ross; Douglas Fleming
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386

Review 3.  Defining complementary and alternative medicine in allergies and asthma: benefits and risks.

Authors:  Jennifer Heimall; Leonard Bielory
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

Review 4.  Complementary and alternative therapy (CAM) in the treatment of allergic rhinitis.

Authors:  J Kern; L Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

5.  The anti-migraine component of butterbur extracts, isopetasin, desensitizes peptidergic nociceptors by acting on TRPA1 cation channel.

Authors:  Silvia Benemei; Francesco De Logu; Simone Li Puma; Ilaria Maddalena Marone; Elisabetta Coppi; Filippo Ugolini; Wolfgang Liedtke; Federica Pollastro; Giovanni Appendino; Pierangelo Geppetti; Serena Materazzi; Romina Nassini
Journal:  Br J Pharmacol       Date:  2017-07-20       Impact factor: 8.739

Review 6.  Herbal Medicines for Allergic Rhinitis: a Systematic Review and Meta-analysis.

Authors:  Minh Phuoc Hoang; Wirach Chitsuthipakorn; Kornkiat Snidvongs
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-25       Impact factor: 4.806

Review 7.  Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology.

Authors:  Raphael Richard Ciuman
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-16       Impact factor: 2.503

Review 8.  Common respiratory diseases.

Authors:  David Kilgore; Wadie Najm
Journal:  Prim Care       Date:  2010-06       Impact factor: 2.907

9.  S-Petasin, the Main Sesquiterpene of Petasites formosanus, Inhibits Phosphodiesterase Activity and Suppresses Ovalbumin-Induced Airway Hyperresponsiveness.

Authors:  Chung-Hung Shih; Tzu-Jung Huang; Chien-Ming Chen; Yun-Lian Lin; Wun-Chang Ko
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-10       Impact factor: 2.629

10.  Complementary therapies in allergic rhinitis.

Authors:  Ibrahim Sayin; Cemal Cingi; Fatih Oghan; Bahadir Baykal; Seckin Ulusoy
Journal:  ISRN Allergy       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.